Literature DB >> 18516669

Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.

Stephen J Spatz1, Cary Rue, Daniel Schumacher, Nikolaus Osterrieder.   

Abstract

Marek's disease (MD) is the leading cause of losses in chicken production in the world. Over the past 40 years significant progress has been made in the control of MD through the use of vaccines which reduce or delay tumor formation in vaccinated flocks. However, these vaccines fail to induce an immune response that protects against infection and virus shedding. Little is known about the genetic changes that lead to attenuation and are necessary for the generation of vaccine strains. Previous research has demonstrated that serial passage of virulent strains in cell culture results in the generation of attenuated progeny. Obtaining detailed knowledge of the changes which are needed for attenuation will be important for advancing our understanding of MD biology and should facilitate the development of more potent vaccines. We have determined the complete nucleotide sequence of a bacterial artificial chromosome (BAC) construct representing the 80th passage of a very virulent plus (vv+) MD virus strain termed 584A. Pathotyping studies have indicated that this strain (584Ap80) is indeed attenuated. Bioinformatic analysis of the sequencing data has identified numerous gross genetic changes clustering in the inverted repeat regions of the genome, as well as subtle changes (single nucleotide polymorphisms or SNPs) scattered throughout the genome. Relative to the parental strain (584Ap9), insertional mutations were identified in the MD-specific genes encoding RLORF1, RLORF3, RLORF6, 23 kDa, RLORF7 (Meq), vIL8, vLip, RSORF1, and five uncharacterized novel genes. Deletions were found in four locations within the 584Ap80 genome. A large deletion (297nt) was found in the diploid genes 85.6/98.6 and a 321 nt deletion within the intergenic region between the U(L)3 and U(L)3.5 genes is predicted to create a fusion polypeptide. A single nucleotide deletion was identified within the origin of replication. Both insertions and deletions were found in the dipoid genes MDV3.4/78.3 encoding the virulence factor RLORF4. The sequencing of the attenuated strain 584Ap80 and comparison to that of the virulent parent 584A passage 9 (584Ap9) has provided a wealth of information regarding genetic changes which have occurred during the attenuation process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516669     DOI: 10.1007/s11262-008-0242-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  45 in total

1.  Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus.

Authors:  M Niikura; J Dodgson; H Cheng
Journal:  Arch Virol       Date:  2005-09-09       Impact factor: 2.574

2.  Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture.

Authors:  C Denesvre; C Blondeau; M Lemesle; Y Le Vern; D Vautherot; P Roingeard; J F Vautherot
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome.

Authors:  M A McVoy; D E Nixon; S P Adler; E S Mocarski
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 4.  Classification of Marek's disease viruses according to pathotype: philosophy and methodology.

Authors:  R L Witter; B W Calnek; C Buscaglia; I M Gimeno; K A Schat
Journal:  Avian Pathol       Date:  2005-04       Impact factor: 3.378

5.  Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.

Authors:  Venugopal Nair
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

6.  A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens.

Authors:  B Karsten Tischer; Daniel Schumacher; Martin Beer; Jörg Beyer; Jens Peter Teifke; Kerstin Osterrieder; Kerstin Wink; Vladimir Zelnik; Frank Fehler; Nikolaus Osterrieder
Journal:  J Gen Virol       Date:  2002-10       Impact factor: 3.891

7.  Selection of Marek's disease virus recombinants expressing the Escherichia coli gpt gene.

Authors:  D R Marshall; J D Reilly; X Liu; R F Silva
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

8.  Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses.

Authors:  R L Witter
Journal:  Avian Dis       Date:  2002 Oct-Dec       Impact factor: 1.577

9.  Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV.

Authors:  Q Peng; M Zeng; Z A Bhuiyan; E Ubukata; A Tanaka; M Nonoyama; Y Shirazi
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

10.  Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.

Authors:  Stephen J Spatz; Robert F Silva
Journal:  Virus Genes       Date:  2006-09-09       Impact factor: 2.198

View more
  12 in total

1.  The ORF012 gene of Marek's disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth.

Authors:  Timo Schippers; Keith Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Herpesvirus systematics.

Authors:  Andrew J Davison
Journal:  Vet Microbiol       Date:  2010-02-11       Impact factor: 3.293

3.  Complete genome sequence of a recombinant Marek's disease virus field strain with one reticuloendotheliosis virus long terminal repeat insert.

Authors:  Shuai Su; Ning Cui; Zhizhong Cui; Peng Zhao; Yanpeng Li; Jiabo Ding; Xuan Dong
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

4.  Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.

Authors:  Yun Cheng; Feng Cong; Yan-ping Zhang; Zhi-jie Li; Na-na Xu; Guang-yu Hou; Chang-Jun Liu
Journal:  Virus Genes       Date:  2012-04-04       Impact factor: 2.332

5.  Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations.

Authors:  Moriah L Szpara; Lance Parsons; L W Enquist
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Marek's disease viruses lacking either R-LORF10 or LORF4 have altered virulence in chickens.

Authors:  Taejoong Kim; Henry D Hunt; Hans H Cheng
Journal:  Virus Genes       Date:  2010-03-13       Impact factor: 2.332

7.  Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.

Authors:  Stephen J Spatz; Jeremy D Volkening; Isabel M Gimeno; Mohammad Heidari; Richard L Witter
Journal:  Virus Genes       Date:  2012-08-26       Impact factor: 2.332

8.  Marek's disease virus late protein expression in feather follicle epithelial cells as early as 8 days postinfection.

Authors:  Keith W Jarosinski
Journal:  Avian Dis       Date:  2012-12       Impact factor: 1.577

9.  Pathogenicity of a very virulent strain of Marek's disease herpesvirus cloned as infectious bacterial artificial chromosomes.

Authors:  Lorraine P Smith; Lawrence J Petherbridge; Susan J Baigent; Jennifer Simpson; Venugopal Nair
Journal:  J Biomed Biotechnol       Date:  2010-11-25

10.  Positive Selection Drives Rapid Evolution of the meq Oncogene of Marek's Disease Virus.

Authors:  Abinash Padhi; Mark S Parcells
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.